OpenLegislation

Division 10.4 SubstancesF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 10.4.1Design and manufacture of devices
  2. 10.4.2Justification regarding the presence of CMR and/or endocrine-disrupting substances
  3. 10.4.3Guidelines on phthalates
  4. 10.4.4Guidelines on other CMR and endocrine-disrupting substances
  5. 10.4.5Labelling

Annotations

Textual amendments

F1

Regulation revoked (31.12.2020) by The Medical Devices Regulations 2002 (S.I. 2002/618), reg. 4O (with savings and transitional provisions for N.I. in reg. 3ZA) (as amended by S.I. 2019/791, regs. 1(1), 3(7) and by S.I. 2020/1478, regs. 1(3), Sch. 2 para. 2; and as amended (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 4, 32); 2020 c. 1, Sch. 5 para. 1(1))